Ani Pharmaceuticals (ANIP) Other Non-Current Liabilities (2016 - 2026)
Ani Pharmaceuticals (ANIP) recorded Other Liabilities of $32.58 million in Q2 2026, down 12.9% from $37.39 million a year earlier and down 5.0% from the prior quarter.
Ani Pharmaceuticals (ANIP) Other Non-Current Liabilities (2016 - 2026) Analysis & Trends
At the end of FY2025, Ani Pharmaceuticals reported Other Liabilities of $30.07 million, down 17.6% from FY2024.
- Annual Other Liabilities has a five-year compound annual growth rate of 15.7% (FY2020 to FY2025).
- Across earlier years, Other Liabilities came in at $36.51 million in FY2024 (-9.9%), $40.53 million in FY2023 (+11.2%), $36.44 million in FY2022 (-6.1%) and $38.8 million in FY2021 (+167.9%).
- Quarterly Other Liabilities has ranged from $8.12 million in Q3 2021 to $40.53 million in Q4 2023 over the past five years.
- On a year-over-year basis, Other Liabilities has declined for four consecutive quarters, with growth averaging 18.6% over the last eight quarters.
- Peak year-over-year performance for Other Liabilities in the last five years was growth of 330.3% in Q3 2022, against a decline of 56.1% in Q1 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $34.3 million (Q1 2026), $30.07 million (Q4 2025) and $30.65 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn |
| 10 | Ani Pharmaceuticals | 1.43 Bn | 212.92 Mn | 165.89 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 32.58 Mn |
| Mar 31, 2026 | 34.30 Mn |
| Dec 31, 2025 | 30.07 Mn |
| Sep 30, 2025 | 30.65 Mn |
| Jun 30, 2025 | 37.39 Mn |
| Mar 31, 2025 | 36.15 Mn |
| Dec 31, 2024 | 36.51 Mn |
| Sep 30, 2024 | 39.92 Mn |
| Jun 30, 2024 | 27.67 Mn |
| Mar 31, 2024 | 27.82 Mn |
| Dec 31, 2023 | 40.53 Mn |
| Sep 30, 2023 | 15.82 Mn |
| Jun 30, 2023 | 16.76 Mn |
| Mar 31, 2023 | 14.46 Mn |
| Dec 31, 2022 | 36.44 Mn |
| Sep 30, 2022 | 34.93 Mn |
| Jun 30, 2022 | 31.97 Mn |
| Mar 31, 2022 | 32.91 Mn |
| Dec 31, 2021 | 38.80 Mn |
| Sep 30, 2021 | 8.12 Mn |
Ani Pharmaceuticals Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=ANIP&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "ANIP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=ANIP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();